Dr Erwin Blomsma, Co-founder & CEO, ViroVet
5
Animal Health Asia 20/10/2016 [email protected] 1 Providing innovative virus control solutions to secure and improve the health and value of livestock > 1.5 billion > 2 billion > 1 billion > 23 billion
-
Upload
kisaco-research -
Category
Business
-
view
69 -
download
0
Transcript of Dr Erwin Blomsma, Co-founder & CEO, ViroVet
Animal Health Asia 20/10/2016
Providing innovative virus control solutions to secure and improve the health and value of livestock
> 1.5 billion > 2 billion
> 1 billion> 23 billion
Animal Health Asia 20/10/2016
3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.50
20
40
60
80
100
120
1960 201019851975 2000billion people
million tonnes
sheep & goat
poultry
eggs
cattle
pigs
middle class
Global meat production
Animal Health Asia 20/10/2016
Our BusinessProviding innovative virus control solutions to secure and improve the health and value of livestock and reduce the use of antibiotics
• Fast acting antiviral drugs– Immediate effect (no immunity gap)– Broad activity across strains– Filtering out infected animals (immune response)
• Better vaccines – Increased efficiency and DIVA– No need for cold chain – Quickly adaptable and low cost
ACTNOW
ACTLONG
Antiviral Technology
Rega Institute for Medical Research Atripla HIV / Hepsera Hepatitis
Active Pharmaceutical Ingredients / NCE
Animal Health Asia 20/10/2016
Vaccine Technology Platform
Rega Institute for Medical Research
Large PharmaCompanies
Yellow fever, Zika, etc
Veterinary Applications of Vaccine Technology
HumanField
Our foundations
44mn$Acquisition January 6, 2014
Rega Institute for Medical Research
€8,5mn Series A on October 17, 2008• New Belgian SME • Probably the first• Product pipeline
• 5 for pets • 2 for livestock
Veterinary rights onHuman Antiviral Drugs
Atripla HIV / Hepsera Hepatitis
• Nasdaq PETX• Development
companyof Pet Products
• FDA priority• EU preparation
Spin-off July 30, 2015
Vaccine technologyNew antivirals
VaccineTechnology
Animal Health Asia 20/10/2016
Feeding the world
70% 80%Increase of caloriesneeded to feed9.5 billion people
Rise in demand of animal based food
1.8bn
>5bn
2010
2050Limited pasture requires smart farming
OutputProductivity
Environmental changesIncrease of vector-borne diseasesGlobalisation (incl tourism)Increased spread of viral diseasesAntibiotic resistance leading to zoonoses80% of all antibiotics are used in livestock
Provide fast acting antiviralsBroad activity, ‘DIVA’, treat & protectLaunch better vaccinesStable, DIVA, low cost, prevent disease
Bovine and Porcine Respiratory Disease ComplexNovel drugs and vaccines for BVD and PRRS, reduce antibioticsEpizootics and emerging zoonotic threatsAntivirals to control ASF, novel flu and RVF vaccines
with innovation
Providing innovative virus control solutions to secure and improve the health and value of livestock
2016
